SANDIMMUN NEORAL caps 10 mg 60 pce

7680526560528 CH-52656 L04AD01 07.15.0.

Reimbursement limitations:

SANDIMMUN NE

Transplantations.
Maladies immunologiques graves ainsi que rares (aussi celles enregistrées sous Possibilité d'emploi), ne répondant …

SANDIMMUN NEORAL caps 10 mg 60 pce
SANDIMMUN NEORAL caps 10 mg 60 pce
SANDIMMUN NEORAL caps 10 mg 60 pce
1 / 3
google

Details

Product number
5265604
CPT
-
Packaging group
60
Unit
Kapsel(n)
Composition
ciclosporinum 10 mg, ethanolum anhydricum 10 mg, propylenglycolum 10 mg, interesterified corn oil, macrogolglyceroli hydroxystearas 40.5 mg, E 307, Kapselhülle: titanii dioxidum, glycerolum (85 per centum) 6.9 mg, propylenglycolum 10.8 mg, gelatina, Drucktinte: E 120, aluminii chloridum hexahydricum, natrii hydroxidum, propylenglycolum, hypromellosum, pro capsula corresp. ethanolum 12 % V/V.

Articles (1)

Sandimmun Neoral 10 mg, Kapseln
Kapseln
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
22/11/2023
Professional SmPC
Français
22/11/2023
Professional SmPC
Italien
22/11/2023
Patient information leaflet
Allemand
16/11/2023
Patient information leaflet
Français
16/11/2023
Patient information leaflet
Italien
16/11/2023

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
10.0 MG Substance HBESI
(N/A)
10.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
40.5 MG Substance HBESI
(N/A)
- Substance ANTOX
(N/A)
- Substance HNIDK
(N/A)
6.9 MG Substance HNIDK
(N/A)
10.8 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 44.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1998

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
52656
Drug name
Sandimmun Neoral, Kapseln
Galenic form
KAPWE
ATC Code
L04AD01
Authorization status
Z
Dispensation category
B
First authorization
16/05/1994
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Immunsuppressivum

Packaging details

Description (FR)
SANDIMMUN NEORAL caps 10 mg 60 pce
Description (DE)
SANDIMMUN NEORAL Kaps 10 mg 60 Stk
Market launch
18/06/1997
Narcotic (BTM)
No

Other packaging sizes

SANDIMMUN NEORAL caps 25 mg 50 pce
50 KAP
View
SANDIMMUN NEORAL caps 50 mg 50 pce
50 KAP
View
SANDIMMUN NEORAL caps 100 mg 50 pce
50 KAP
View